Healthcare startup ekincare raises over Rs 25 crore in Series A funding

Published On 2019-11-14 04:40 GMT   |   Update On 2019-11-14 04:40 GMT

New Delhi: Health benefits start-up ekincare on Wednesday said it has raised USD 3.6 million (about 25.8 crores) in a funding round from investors like Ventureast and Eight Roads.


The round was led by a new investor (whose name the company did not disclose), with participation from existing investors including Ventureast, Eight Roads and Touchstone equities, a statement said.

The latest round takes the total funding raised by ekincare to USD 5.6 million, it added.

The funds will be used to strengthen ekincare's technology platform, business development, marketing and expand its portfolio of offerings in the corporate health benefits market, the statement said.

Also Read: Onco.com, dedicated cancer care platform, raises $7 million in Series A funding


Currently, ekincare caters to over 200 companies, managing health of more than three lakh employees on its platform. It offers preventive health services like telemedicine, e-pharmacy, health checks, vision and dental care, access to gyms, and other services.


Citing a report by Transparency Market Research, the company said the corporate health market size in the Asia Pacific was valued at USD 4.5 billion in 2018 and, is expected to grow at a CAGR (Compound annual growth rate) of 9 per cent over the next 10 years.

"Our patent-pending technology recognises patterns across disparate health data sets, discerning differences between consumer segments and behaviours to engage people better," ekincare founder and CEO Kiran Kalakuntla said

Also Read: HealthAssure raises over Rs 17 crore in Series A funding led by Blume Ventures
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News